Riskpilot← Back to searchSign inGet full accessPOSEIDON PHARMACEUTICALS A/S
A/SDissolvedCVR 26133130Strandvejen 60Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900Est. 2001— employees
Revenue 2015
—
EBITDA margin
—
0% vs 2014
Equity ratio
100.0%
Financial strength
Net profit 2015
DKK 143K
+1% vs 2014
| Revenue | — | — |
| EBITDA | DKK -17K | +0% |
| Net profit | DKK 143K | +1% |
| Total assets | DKK 64M | +0% |
| Equity | DKK 64M | +0% |
| Employees | — | — |
Legal name
POSEIDON PHARMACEUTICALS A/S
CVR number
26133130
Legal form
Aktieselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
2. juli 2001
Share capital
DKK 10.500.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2015-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to af bestyrelsens medlemmer i forening eller af et bestyrelsesmedlem i fællesskab med en direktør.
Address
Strandvejen 60
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | -17 | -19 | -17 | -17 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -17 | -19 | -17 | -17 |
| Net financials | 211 | 159 | 159 | 160 |
| Profit before tax | 194 | 140 | 142 | 143 |
| Tax | -0 | -0 | -0 | -0 |
| Net profit | 194 | 140 | 142 | 143 |
| Item | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|
| Total assets | 63.555 | 63.695 | 63.837 | 63.980 |
| Equity | 63.540 | 63.680 | 63.822 | 63.965 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 15 | 15 | 15 | 15 |
| Total debt | 15 | 15 | 15 | 15 |
EBITDA margin
-1700000.0%
This company
15.8%
Market median
-10759594% vs market
20122015
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20122015
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20122015
Net profit margin
14300000.0%
This company
8.1%
Market median
+176543110% vs market
20122015
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122015
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122015
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SO Management | Management | 2001 | — | — |
AM Management | Management | 2009 | — | — |
HF Management | Management | 2001 | — | — |
JV Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2010 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2001 | — | — | |
| Chairman | 2013 | — | — | |
| Chairman | 2013 | — | — | |
| Chairman | 2001 | — | — | |
| Board of Directors | 2001 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NTG Nordic Transport Group A/S | Company | 100.0% | 0.0% | 2001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of POSEIDON PHARMACEUTICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren-Peter Olesen | Management | 0 companies |
| Anita Milland | Management | 0 companies |
| Helle Freundlich Andersen | Management | 0 companies |
| Jette Vibeke Møllmann | Chief Executive Officer | 0 companies |
| Jeppe Jensen | Chairman | 0 companies |
| Jørgen Buus Lassen | Board of Directors | 0 companies |
| Christian Dilling Elkjær Lundgren | Board of Directors | 0 companies |
| Bo Skaaning Jensen | Board of Directors | 0 companies |
| René Schneider | Chairman | 0 companies |
| Allan Andersen | Chairman | 0 companies |
| Flemming Pedersen | Chairman | 0 companies |
| Jørgen Drejer | Board of Directors | 0 companies |